-
30-11-2018, 03:36 PM
#16681
Hey Balance, you will be thrilled to know that Kaiser is still mentioned
"The USA market remains the priority for Pacific Edge. Management is focused on completing agreements and building sales from the large institutional accounts and payers it is targeting, including Kaiser Permanente, the recently announced Johns Hopkins Medicine, the Veterans Administration and Tricare, the CMS and other blue chip institutions."
They also have another "new found market" of Australia, hopefully the "First Class" airfares to there cost less. There was some mumbling at the AGM of a hospital in Adelaide (or maybe all of South Australia?) coming on board, but all we have is crickets so far.
-
02-12-2018, 09:50 AM
#16682
Originally Posted by Arthur
Hey Balance, you will be thrilled to know that Kaiser is still mentioned
"The USA market remains the priority for Pacific Edge. Management is focused on completing agreements and building sales from the large institutional accounts and payers it is targeting, including Kaiser Permanente, the recently announced Johns Hopkins Medicine, the Veterans Administration and Tricare, the CMS and other blue chip institutions."
They also have another "new found market" of Australia, hopefully the "First Class" airfares to there cost less. There was some mumbling at the AGM of a hospital in Adelaide (or maybe all of South Australia?) coming on board, but all we have is crickets so far.
Timeline of PEB's deal with Kaiser :
Nov 14th 2016 : "successfully completed its analysis of the data from the large scale Kaiser Permanente (Kaiser) User Programme with positive and compelling findings.
Aug 24th 2017 : "Kaiser .... we are now nearing the end of the negotiations on a commercial agreement"
Nov 29th 2017 : "Commercial negotiations are progressing positively with Kaiser Permanente"
April 19th 2018 : "Making good progress"
May 22th 2018 : "The commercial agreement continues to move forward"
Nov 28th 2018 : ", targeting, including Kaiser Permanente"
Deal is DEAD.
-
02-12-2018, 09:55 AM
#16683
https://www.odt.co.nz/business/pacif...se-further-12m
"As at the end of March Pacific Edge had $16.2million cash in hand and at the end of September $10million, which implied a monthly cash burn of $1.03million.
However, Craigs Investment Partners broker Peter McIntyre said actual operating expenses for the six months to September amounted to $11.35 million - equating to almost $1.9million a month."
$122m in losses and cash burn since it started and no sign of that $100m sales.
But have no fear - it's all around the corner! Just several more capital raisings to go!
-
02-12-2018, 10:31 AM
#16684
Originally Posted by Balance
Timeline of PEB's deal with Kaiser :
Nov 14th 2016 : "successfully completed its analysis of the data from the large scale Kaiser Permanente (Kaiser) User Programme with positive and compelling findings.
Aug 24th 2017 : "Kaiser .... we are now nearing the end of the negotiations on a commercial agreement"
Nov 29th 2017 : "Commercial negotiations are progressing positively with Kaiser Permanente"
April 19th 2018 : "Making good progress"
May 22th 2018 : "The commercial agreement continues to move forward"
Nov 28th 2018 : ", targeting, including Kaiser Permanente"
Deal is DEAD.
Did it occur to you that perhaps Kaiser may have been waiting for a USA national reimbursement being receipt of product codes and notification of a national price (US$760 per test)?
They would be needed for billing purposes for such a large outfit.
Bladder cancer and CXbladder is probably not the highest item on the things to do list but the cost cutting possibilites list might be a different story especially now the Monitor test has become available.
-
02-12-2018, 04:02 PM
#16685
Originally Posted by Minerbarejet
Did it occur to you that perhaps Kaiser may have been waiting for a USA national reimbursement being receipt of product codes and notification of a national price (US$760 per test)?
They would be needed for billing purposes for such a large outfit.
Bladder cancer and CXbladder is probably not the highest item on the things to do list but the cost cutting possibilites list might be a different story especially now the Monitor test has become available.
Nope - deal is DEAD.
-
02-12-2018, 04:17 PM
#16686
Originally Posted by Minerbarejet
Did it occur to you that perhaps Kaiser may have been waiting for a USA national reimbursement being receipt of product codes and notification of a national price (US$760 per test)?
.
In which case PEB (with their never ending optimism), would have announced "we are 2 and 9/10's on the way to securing a deal with KP, but for completion of the national reimbursement confirmations"
-
02-12-2018, 04:22 PM
#16687
Originally Posted by minimoke
In which case PEB (with their never ending optimism), would have announced "we are 2 and 9/10's on the way to securing a deal with KP, but for completion of the national reimbursement confirmations"
Exactly.
Especially with yet another (never ending) capital raising.
-
05-12-2018, 10:27 AM
#16688
-
05-12-2018, 02:01 PM
#16689
That is great news. Hopefully it will be on the market soon - note it does not tell you what cancer you have. Peeing in a jar to rule out bladder cancer may increase with the new test.
-
05-12-2018, 03:16 PM
#16690
Originally Posted by Arthur
That is great news. Hopefully it will be on the market soon - note it does not tell you what cancer you have. Peeing in a jar to rule out bladder cancer may increase with the new test.
I suppose there would be a process of elimination to try to diagnose where the cancer was. Im not sure this test would be used for that purpose or not.
If you were having bladder problems ,I would imagine the other ,cheaper test would come first.then maybe PEB test?
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks